Subcellular targeting and dynamic regulation of PTEN: Implications for neuronal cells and neurological disorders

Frontiers in Molecular Neuroscience

Volumn 7, Issue 1 APR, 2014, Pages

  Kreis, Patricia ^a   Leondaritis, George ^a,b   Lieberam, Ivo ^a   Eickholt, Britta J ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Membranes; Neuronal morphology; PI3K AKT mTOR; PTEN phosphohydrolase; Synaptic transmission

Indexed keywords

CELL MEMBRANE PROTEIN; ISOPROTEIN; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTISM; CELL NUCLEUS; CELLULAR DISTRIBUTION; CELLULAR SECRETION; CONFORMATIONAL TRANSITION; CYTOSKELETON; DENDRITIC SPINE; ENDOPLASMIC RETICULUM; HAMARTOMA; HUMAN; INTRACELLULAR SIGNALING; LIPID RAFT; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MUTATION; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER REGENERATION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PARKINSON DISEASE; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; REVIEW; SPINAL MUSCULAR ATROPHY; TRANSCRIPTION REGULATION;

EID: 84897460431     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00023     Document Type: Review

References (170)

1. Amiri, A., Cho, W., Zhou, J., Birnbaum, S. G., Sinton, C. M., McKay, R. M., et al. (2012). Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. J. Neurosci. 32, 5880-5890. doi: 10.1523/JNEUROSCI.5462-11.2012
2. Aoki, K., Nakamura, T., Inoue, T., Meyer, T., and Matsuda, M. (2007). An essential role for the SHIP2-dependent negative feedback loop in neuritogenesis of nerve growth factor-stimulated PC12 cells. J. Cell Biol. 177, 817-827. doi: 10.1083/jcb.200609017
3. Arendt, K. L., Royo, M., Fernández-Monreal, M., Knafo, S., Petrok, C. N., Martens, J. R., et al. (2010). PIP3 controls synaptic function by maintaining AMPA receptor clustering at the postsynaptic membrane. Nat. Neurosci. 13, 36-44. doi: 10.1038/nn.2462
4. Backman, S. A., Stambolic, V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., et al. (2001). Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29, 396-403. doi: 10.1038/ng782
5. Bassi, C., Ho, J., Srikumar, T., Dowling, R. J. O., Gorrini, C., Miller, S. J., et al. (2013). Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 341, 395-399. doi: 10.1126/science.1236188
6. Bolduc, D., Rahdar, M., Tu-Sekine, B., Sivakumaren, S. C., Raben, D., Amzel, L. M., et al. (2013). Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis. Elife 2:e00691. doi: 10.7554/eLife.00691
7. Bononi, A., Bonora, M., Marchi, S., Missiroli, S., Poletti, F., Giorgi, C., et al. (2013). Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ. 20, 1631-1643. doi: 10.1038/cdd.2013.77
8. Butler, M. G., Dasouki, M. J., Zhou, X.-P., Talebizadeh, Z., Brown, M., Takahashi, T. N., Miles, J. H., Wang, C. H., Stratton, R., Pilarski, R., et al. (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 42, 318-321. doi: 10.1136/jmg.2004.024646
9. Buxbaum, J. D., Cai, G., Chaste, P., Nygren, G., Goldsmith, J., Reichert, J., et al. (2007). Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 484-491. doi: 10.1002/ajmg.b.30493
10. Cao, J., Wan, L., Hacker, E., Dai, X., Lenna, S., Jimenez-Cervantes, C., et al. (2013). MC1R is a potent regulator of PTEN after UV exposure in melanocytes. Mol. Cell 51, 409-422. doi: 10.1016/j.molcel.2013.08.010
11. Caselli, A., Mazzinghi, B., Camici, G., Manao, G., and Ramponi, G. (2002). Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1. Biochem. Biophys. Res. Commun. 296, 692-697. doi: 10.1016/S0006-291X(02)00928-2
12. Chadborn, N. H., Ahmed, A. I., Holt, M. R., Prinjha, R., Dunn, G. A., Jones, G. E., et al. (2006). PTEN couples Sema3A signalling to growth cone collapse. J. Cell Sci. 119, 951-957. doi: 10.1242/jcs.02801
13. Chagpar, R. B., Links, P. H., Pastor, M. C., Furber, L. A., Hawrysh, A. D., Chamberlain, M. D., et al. (2010). Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 107, 5471-5476. doi: 10.1073/pnas.0908899107
14. Cheung, N. S., Choy, M. S., Halliwell, B., Teo, T. S., Bay, B. H., Lee, A. Y., et al. (2004). Lactacystin-induced apoptosis of cultured mouse cortical neurons is associated with accumulation of PTEN in the detergent-resistant membrane fraction. Cell Mol. Life Sci. 61, 1926-1934. doi: 10.1007/s00018-004-4127-7
15. Chivet, M., Javalet, C., Hemming, F., Pernet-Gallay, K., Laulagnier, K., Fraboulet, S., et al. (2013). Exosomes as a novel way of interneuronal communication. Biochem. Soc. Trans. 41, 241-244. doi: 10.1042/BST20120266
16. Choy, M. S., Bay, B. H., Cheng, H. C., and Cheung, N. S. (2006). PTEN is recruited to specific microdomains of the plasma membrane during lactacystin-induced neuronal apoptosis. Neurosci. Lett. 405, 120-125. doi: 10.1016/j.neulet.2006.06.037
17. Christie, K. J., Webber, C. A., Martinez, J. A., Singh, B., and Zochodne, D. W. (2010). PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J. Neurosci. 30, 9306-9315. doi: 10.1523/JNEUROSCI.6271-09.2010
18. Chung, J.-H., Ginn-Pease, M. E., and Eng, C. (2005). Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res. 65, 4108-4116. doi: 10.1158/0008-5472.CAN-05-0124
19. Conti, S., Condò, M., Posar, A., Mari, F., Resta, N., Renieri, A., et al. (2012). Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy. J. Child Neurol. 27, 392-397. doi: 10.1177/0883073811420296
20. Costa-Mattioli, M., and Monteggia, L. M. (2013). mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat. Neurosci. 16, 1537-1543. doi: 10.1038/nn.3546
21. Diaz-Ruiz, O., Zapata, A., Shan, L., Zhang, Y., Tomac, A. C., Malik, N., et al. (2009). Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons. PloS ONE 4:e7027. doi: 10.1371/journal.pone.0007027
22. Ding, J., Guo, J., Yuan, Q., Yuan, F., Chen, H., and Tian, H. (2013). Inhibition of phosphatase and tensin homolog deleted on chromosome 10 decreases rat cortical neuron injury and blood-brain barrier permeability, and improves neurological functional recovery in traumatic brain injury model. PloS ONE 8:e80429. doi: 10.1371/journal.pone.0080429
23. Di Paolo, G., and De Camilli, P. (2006). Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657. doi: 10.1038/nature05185
24. Domanskyi, A., Geissler, C., Vinnikov, I. A., Alter, H., Schober, A., Vogt, M. A., et al. (2011). Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. FASEB J. 25, 2898-2910. doi: 10.1096/fj.11-181958
25. Doré, S., Kar, S., and Quirion, R. (1997). Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid-and human amylin-induced toxicity. Proc. Natl. Acad. Sci. U.S.A. 94, 4772-4777.
26. Drinjakovic, J., Jung, H., Campbell, D. S., Strochlic, L., Dwivedy, A., and Holt, C. E. (2010). E3 ligase Nedd4 promotes axon branching by downregulating PTEN. Neuron 65, 341-357. doi: 10.1016/j.neuron.2010.01.017
27. Eickholt, B. J., Ahmed, A. I., Davies, M., Papakonstanti, E. A., Pearce, W., Starkey, M. L., et al. (2007). Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase. PLoS ONE 2:e869. doi: 10.1371/journal.pone.0000869
28. Eng, C. (2003). PTEN: one gene, many syndromes. Hum. Mutat. 22, 183-198. doi: 10.1002/humu.10257
29. Fenton, T. R., Nathanson, D., Ponte de Albuquerque, C., Kuga, D., Iwanami, A., Dang, J., et al. (2012). Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240. Proc. Natl. Acad. Sci. U.S.A. 109, 14164-14169. doi: 10.1073/pnas.1211962109
30. Fine, B., Hodakoski, C., Koujak, S., Su, T., Saal, L. H., Maurer, M., et al. (2009). Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 325, 1261-1265. doi: 10.1126/science.1173569
31. Fraser, M. M., Bayazitov, I. T., Zakharenko, S. S., and Baker, S. J. (2008). Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 151, 476-488. doi: 10.1016/j.neuroscience.2007.10.048
32. Fraser, M. M., Zhu, X., Kwon, C.-H., Uhlmann, E. J., Gutmann, D. H., and Baker, S. J. (2004). Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res. 64, 7773-7779. doi: 10.1158/0008-5472.CAN-04-2487
33. Freeman, D. J., Li, A. G., Wei, G., Li, H.-H., Kertesz, N., Lesche, R., et al. (2003). PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and-independent mechanisms. Cancer Cell 3, 117-130. doi: 10.1016/S1535-6108(03)00021-7
34. Fritsch, R., de Krijger, I., Fritsch, K., George, R., Reason, B., Kumar, M. S., et al. (2013). RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. Cell 153, 1050-1063. doi: 10.1016/j.cell.2013.04.031
35. Frühbeis, C., Fröhlich, D., Kuo, W. P., and Krämer-Albers, E.-M. (2013). Extracellular vesicles as mediators of neuron-glia communication. Front. Cell. Neurosci. 7:182. doi: 10.3389/fncel.2013.00182
36. Fujimoto, M., and Hayashi, T. (2011). New insights into the role of mitochondria-associated endoplasmic reticulum membrane. Int. Rev. Cell Mol. Biol. 292, 73-117. doi: 10.1016/B978-0-12-386033-0.00002-5
37. Gabriel, K., Ingram, A., Austin, R., Kapoor, A., Tang, D., Majeed, F., et al. (2013). Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer. PloS ONE 8:e70047. doi: 10.1371/journal.pone.0070047
38. Gallo, G. (2013). More than one ring to bind them all: recent insights into the structure of the axon. Dev. Neurobiol. 73, 799-805. doi: 10.1002/dneu.22100
39. Gao, X., Lowry, P. R., Zhou, X., Depry, C., Wei, Z., Wong, G. W., et al. (2011). PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc. Natl. Acad. Sci. U.S.A. 108, 14509-14514. doi: 10.1073/pnas.1019386108
40. Gil, A., Andrés-Pons, A., Fernéndez, E., Valiente, M., Torres, J., Cervera, J., et al. (2006). Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol. Biol. Cell 17, 4002-4013. doi: 10.1091/mbc.E06-05-0380
41. Gimm, O., Perren, A., Weng, L. P., Marsh, D. J., Yeh, J. J., Ziebold, U., et al. (2000). Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am. J. Pathol. 156, 1693-1700. doi: 10.1016/S0002-9440(10)65040-7
42. Goh, C.-P., Putz, U., Howitt, J., Low, L.-H., Gunnersen, J., Bye, N., et al. (2013). Nuclear trafficking of Pten after brain injury leads to neuron survival not death. Exp. Neurol. 252C, 37-46. doi: 10.1016/j.expneurol.2013.11.017
43. González-Santamaría, J., Campagna, M., Ortega-Molina, A., Marcos-Villar, L., de la Cruz-Herrera, C. F., González, D., et al. (2012). Regulation of the tumor suppressor PTEN by SUMO. Cell Death Dis. 3, e393. doi: 10.1038/cddis.2012.135
44. Goswami, R., Singh, D., Phillips, G., Kilkus, J., and Dawson, G. (2005). Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines. J. Neurosci. Res. 81, 541-550. doi: 10.1002/jnr.20550
45. Griffin, R. J., Moloney, A., Kelliher, M., Johnston, J. A., Ravid, R., Dockery, P., et al. (2005). Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem. 93, 105-117. doi: 10.1111/j.1471-4159.2004.02949.x
46. Groszer, M., Erickson, R., Scripture-Adams, D. D., Lesche, R., Trumpp, A., Zack, J. A., et al. (2001). Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294, 2186-2189. doi: 10.1126/science.1065518
47. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J. P., and Anderton, B. H. (1992). Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62. doi: 10.1016/0304-3940(92)90774-2
48. Hawkins, P. T., Anderson, K. E., Davidson, K., and Stephens, L. R. (2006). Signalling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 34, 647-662. doi: 10.1042/BST0340647
49. Haws, M. E., Jaramillo, T. C., Espinosa-Becerra, F., Widman, A., Stuber, G. D., Sparta, D. R., et al. (2014). PTEN knockdown alters dendritic spine/protrusion morphology, not density. J. Comp. Neurol. 522, 1171-1190. doi: 10.1002/cne.23488
50. Hayashi, K., Ishikawa, R., Ye, L. H., He, X. L., Takata, K., Kohama, K., et al. (1996). Modulatory role of drebrin on the cytoskeleton within dendritic spines in the rat cerebral cortex. J. Neurosci. 16, 7161-7170.
51. Hedskog, L., Pinho, C. M., Filadi, R., Ronnback, A., Hertwig, L., Wiehager, B., et al. (2013). Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl. Acad. Sci. U.S.A. 110, 7916-7921. doi: 10.1073/pnas.1300677110
52. Henle, S. J., Carlstrom, L. P., Cheever, T. R., and Henley, J. R. (2013). Differential role of PTEN phosphatase in chemotactic growth cone guidance. J. Biol. Chem. 288, 20837-20842. doi: 10.1074/jbc.C113.487066
53. Henle, S. J., Wang, G., Liang, E., Wu, M., Poo, M.-M., and Henley, J. R. (2011). Asymmetric PI(3,4,5)P3 and Akt signaling mediates chemotaxis of axonal growth cones. J. Neurosci. 31, 7016-7027. doi: 10.1523/JNEUROSCI.0216-11.2011
54. Hobert, J. A., Embacher, R., Mester, J. L., Frazier, T. W. 2nd., and Eng, C. (2014). Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly. Eur. J. Hum. Genet. 22, 273-276. doi: 10.1038/ejhg.2013.114
55. Hodakoski, C., Hopkins, B. D., Barrows, D., Mense, S. M., Keniry, M., Anderson, K. E., et al. (2014). Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis. Proc. Natl. Acad. Sci. U.S.A. 111, 155-160. doi: 10.1073/pnas.1213773111
56. Hopkins, B. D., Fine, B., Steinbach, N., Dendy, M., Rapp, Z., Shaw, J., et al. (2013). A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science 341, 399-402. doi: 10.1126/science.1234907
57. Howitt, J., Lackovic, J., Low, L.-H., Naguib, A., Macintyre, A., Goh, C.-P., et al. (2012). Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. J. Cell Biol. 196, 29-36. doi: 10.1083/jcb.201105009
58. Huang, J., Yan, J., Zhang, J., Zhu, S., Wang, Y., Shi, T., et al. (2012). SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Nat. Commun. 3, 911. doi: 10.1038/ncomms1919.
59. Hur, E.-M., and Zhou, F.-Q. (2010). GSK3 signalling in neural development. Nat. Rev. Neurosci. 11, 539-551. doi: 10.1038/nrn2870
60. Inoue, K., Rispoli, J., Yang, L., Macleod, D., Beal, M. F., Klann, E., et al. (2013). Coordinate regulation of mature dopaminergic axon morphology by macroautophagy and the PTEN signaling pathway. PLoS Genet. 9:e1003845. doi: 10.1371/journal.pgen.1003845
61. Jurado, S., Benoist, M., Lario, A., Knafo, S., Petrok, C. N., and Esteban, J. A. (2010). PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression. EMBO J. 29, 2827-2840. doi: 10.1038/emboj.2010.160
62. Kakumoto, T., and Nakata, T. (2013). Optogenetic control of PIP3: PIP3 is sufficient to induce the actin-based active part of growth cones and is regulated via endocytosis. PloS ONE 8:e70861. doi: 10.1371/journal.pone.0070861
63. Karunarathne, W. K. A., Giri, L., Patel, A. K., Venkatesh, K. V., and Gautam, N. (2013). Optical control demonstrates switch-like PIP3 dynamics underlying the initiation of immune cell migration. Proc. Natl. Acad. Sci. U.S.A. 110, E1575-1583. doi: 10.1073/pnas.1220755110
64. Kavela, S., Shinde, S. R., Ratheesh, R., Viswakalyan, K., Bashyam, M. D., Gowrishankar, S., et al. (2013). PNUTS functions as a proto-oncogene by sequestering PTEN. Cancer Res. 73, 205-214. doi: 10.1158/0008-5472.CAN-12-1394
65. Kerr, F., Rickle, A., Nayeem, N., Brandner, S., Cowburn, R. F., and Lovestone, S. (2006). PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS Lett. 580, 3121-3128. doi: 10.1016/j.febslet.2006.04.064
66. Ketschek, A., and Gallo, G. (2010). Nerve growth factor induces axonal filopodia through localized microdomains of phosphoinositide 3-kinase activity that drive the formation of cytoskeletal precursors to filopodia. J. Neurosci. 30, 12185-12197. doi: 10.1523/JNEUROSCI.1740-10.2010
67. Kim, J.-I., Lee, H.-R., Sim, S., Baek, J., Yu, N.-K., Choi, J.-H., et al. (2011a). PI3Kγ is required for NMDA receptor-dependent long-term depression and behavioral flexibility. Nat. Neurosci. 14, 1447-1454. doi: 10.1038/nn.2937
68. Kim, J.-S., Xu, X., Li, H., Solomon, D., Lane, W. S., Jin, T., et al. (2011b). Mechanistic analysis of a DNA damage-induced, PTEN-dependent size checkpoint in human cells. Mol. Cell. Biol. 31, 2756-2771. doi: 10.1128/MCB.01323-10
69. Kirby, J., Ning, K., Ferraiuolo, L., Heath, P. R., Ismail, A., Kuo, S.-W., et al. (2011). Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134, 506-517. doi: 10.1093/brain/awq345
70. Klein, S., Sharifi-Hannauer, P., and Martinez-Agosto, J. A. (2013). Macrocephaly as a clinical indicator of genetic subtypes in autism. Autism Res. 6, 51-56. doi: 10.1002/aur.1266
71. Krause, M., Leslie, J. D., Stewart, M., Lafuente, E. M., Valderrama, F., Jagannathan, R., et al. (2004). Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. Dev. Cell 7, 571-583. doi: 10.1016/j.devcel.2004.07.024
72. Kreis, P., Hendricusdottir, R., Kay, L., Papageorgiou, I. E., van Diepen, M., Mack, T., et al. (2013). Phosphorylation of the actin binding protein Drebrin at S647 is regulated by neuronal activity and PTEN. PLoS ONE 8:e71957. doi: 10.1371/journal.pone.0071957
73. Kreis, P., van Diepen, M. T., and Eickholt, B. J. (2010). Regulation of PTEN in neurons by myosin-based transport mechanisms. Adv. Enzyme Regul. 50, 119-124. doi: 10.1016/j.advenzreg.2009.10.014
74. Krugmann, S., Anderson, K. E., Ridley, S. H., Risso, N., McGregor, A., Coadwell, J., et al. (2002). Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 9, 95-108. doi: 10.1016/S1097-2765(02)00434-3
75. Kwak, Y.-D., Ma, T., Diao, S., Zhang, X., Chen, Y., Hsu, J., et al. (2010). NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol. Neurodegener. 5, 49. doi: 10.1186/1750-1326-5-49
76. Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., et al. (2006). Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377-388. doi: 10.1016/j.neuron.2006.03.023
77. Kwon, C. H., Zhu, X., Zhang, J., Knoop, L. L., Tharp, R., Smeyne, R. J., et al. (2001). Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat. Genet. 29, 404-411. doi: 10.1038/ng781
78. Lachlan, K. L., Lucassen, A. M., Bunyan, D., and Temple, I. K. (2007). Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J. Med. Genet. 44, 579-585. doi: 10.1136/jmg.2007.049981
79. Lachyankar, M. B., Sultana, N., Schonhoff, C. M., Mitra, P., Poluha, W., Lambert, S., et al. (2000). A role for nuclear PTEN in neuronal differentiation. J. Neurosci. 20, 1404-1413.
80. Lee, J. O., Yang, H., Georgescu, M. M., Di Cristofano, A., Maehama, T., Shi, Y., et al. (1999). Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323-334. doi: 10.1016/S0092-8674(00)81663-3
81. Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L., and Downes, C. P. (2008). Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27, 5464-5476. doi: 10.1038/onc.2008.243
82. Li, Z., Dong, X., Dong, X., Wang, Z., Liu, W., Deng, N., et al. (2005). Regulation of PTEN by Rho small GTPases. Nat. Cell Biol. 7, 399-404. doi: 10.1038/ncb1236
83. Lian, Z., and Di Cristofano, A. (2005). Class reunion: PTEN joins the nuclear crew. Oncogene 24, 7394-7400. doi: 10.1038/sj.onc.1209089
84. Lima-Fernandes, E., Enslen, H., Camand, E., Kotelevets, L., Boularan, C., Achour, L., et al. (2011). Distinct functional outputs of PTEN signalling are controlled by dynamic association with beta-arrestins. EMBO J. 30, 2557-2568. doi: 10.1038/emboj.2011.178
85. Lindhurst, M. J., Sapp, J. C., Teer, J. K., Johnston, J. J., Finn, E. M., Peters, K., et al. (2011). A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N. Engl. J. Med. 365, 611-619. doi: 10.1056/NEJMoa1104017
86. Lindsay, Y., McCoull, D., Davidson, L., Leslie, N. R., Fairservice, A., Gray, A., et al. (2006). Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J. Cell Sci. 119, 5160-5168. doi: 10.1242/jcs.000133
87. Liu, K., Lu, Y., Lee, J. K., Samara, R., Willenberg, R., Sears-Kraxberger, I., et al. (2010). PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 1075-1081. doi: 10.1038/nn.2603
88. Luikart, B. W., Schnell, E., Washburn, E. K., Bensen, A. L., Tovar, K. R., and Westbrook, G. L. (2011). Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J. Neurosci. 31, 4345-4354. doi: 10.1523/JNEUROSCI.0061-11.2011
89. Lumb, C. N., and Sansom, M. S. P. (2013). Defining the membrane-associated state of the PTEN tumor suppressor protein. Biophys. J. 104, 613-621. doi: 10.1016/j.bpj.2012.12.002
90. Luo, X., and Park, K. K. (2012). Neuron-intrinsic inhibitors of axon regeneration: PTEN and SOCS3. Int. Rev. Neurobiol. 105, 141-173. doi: 10.1016/B978-0-12-398309-1.00008-1
91. Maccario, H., Perera, N. M., Gray, A., Downes, C. P., and Leslie, N. R. (2010). Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress. J. Biol. Chem. 285, 12620-12628. doi: 10.1074/jbc.M109.072280
92. Malaney, P., Pathak, R. R., Xue, B., Uversky, V. N., and Dave, V. (2013). Intrinsic disorder in PTEN and its interactome confers structural plasticity and functional versatility. Sci. Rep. 3:2035. doi: 10.1038/srep02035
93. Mao, L., Jia, J., Zhou, X., Xiao, Y., Wang, Y., Mao, X., et al. (2013). Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke. Neuroscience 231, 272-281. doi: 10.1016/j.neuroscience.2012.11.050
94. McBride, K. L., Varga, E. A., Pastore, M. T., Prior, T. W., Manickam, K., Atkin, J. F., et al. (2010). Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 3, 137-141. doi: 10.1002/aur.132
95. Mester, J., and Eng, C. (2013). When overgrowth bumps into cancer: the PTEN-opathies. Am. J. Med. Genet. C Semin. Med. Genet. 163C, 114-121. doi: 10.1002/j.1552-4876.2013.31364.x
96. Mester, J. L., Tilot, A. K., Rybicki, L. A., Frazier, T. W. 2nd., and Eng, C. (2011). Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur. J. Hum. Genet. 19, 763-768. doi: 10.1038/ejhg.2011.20
97. Molina, J. R., Agarwal, N. K., Morales, F. C., Hayashi, Y., Aldape, K. D., Cote, G., et al. (2012). PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene 31, 1264-1274. doi: 10.1038/onc.2011.324
98. Moncalero, V. L., Costanzo, R. V., Perandones, C., and Radrizzani, M. (2011). Different conformations of phosphatase and tensin homolog, deleted on chromosome 10 (PTEN) protein within the nucleus and cytoplasm of neurons. PloS ONE 6:e18857. doi: 10.1371/journal.pone.0018857
99. Mund, T., and Pelham, H. R. B. (2010). Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2. Proc. Natl. Acad. Sci. U.S.A. 107, 11429-11434. doi: 10.1073/pnas.0911714107
100. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., et al. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. U.S.A. 95, 13513-13518. doi: 10.1073/pnas.95.23.13513
101. Nguyen, H. N., Afkari, Y., Senoo, H., Sesaki, H., Devreotes, P. N., and Iijima, M. (2013). Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium. Oncogene. doi: 10.1038/onc.2013.507. [Epub ahead of print].
102. Ning, K., Drepper, C., Valori, C. F., Ahsan, M., Wyles, M., Higginbottom, A., et al. (2010). PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons. Hum. Mol. Genet. 19, 3159-3168. doi: 10.1093/hmg/ddq226
103. Odriozola, L., Singh, G., Hoang, T., and Chan, A. M. (2007). Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J. Biol. Chem. 282, 23306-23315. doi: 10.1074/jbc.M611240200
104. Oinuma, I., Ito, Y., Katoh, H., and Negishi, M. (2010). Semaphorin 4D/Plexin-B1 stimulates PTEN activity through R-Ras GTPase-activating protein activity, inducing growth cone collapse in hippocampal neurons. J. Biol. Chem. 285, 28200-28209. doi: 10.1074/jbc.M110.147546
105. Orloff, M. S., He, X., Peterson, C., Chen, F., Chen, J.-L., Mester, J. L., et al. (2013). Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes. Am. J. Hum. Genet. 92, 76-80. doi: 10.1016/j.ajhg.2012.10.021
106. Orrico, A., Galli, L., Buoni, S., Orsi, A., Vonella, G., and Sorrentino, V. (2009). Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin. Genet. 75, 195-198. doi: 10.1111/j.1399-0004.2008.01074.x
107. Papakonstanti, E. A., Ridley, A. J., and Vanhaesebroeck, B. (2007). The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO J. 26, 3050-3061. doi: 10.1038/sj.emboj.7601763
108. Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., et al. (2008). Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322, 963-966. doi: 10.1126/science.1161566
109. Perdigoto, A. L., Chaudhry, N., Barnes, G. N., Filbin, M. T., and Carter, B. D. (2011). A novel role for PTEN in the inhibition of neurite outgrowth by myelin-associated glycoprotein in cortical neurons. Mol. Cell. Neurosci. 46, 235-244. doi: 10.1016/j.mcn.2010.09.006
110. Pilarski, R., Burt, R., Kohlman, W., Pho, L., Shannon, K. M., and Swisher, E. (2013). Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J. Natl. Cancer Inst. 105, 1607-1616. doi: 10.1093/jnci/djt277
111. Planchon, S. M., Waite, K. A., and Eng, C. (2008). The nuclear affairs of PTEN. J. Cell Sci. 121, 249-253. doi: 10.1242/jcs.022459
112. Putz, U., Howitt, J., Doan, A., Goh, C.-P., Low, L.-H., Silke, J., et al. (2012). The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci. Signal. 5:ra70. doi: 10.1126/scisignal.2003084
113. Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S., and Hall, A. (2004). Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303, 1179-1181. doi: 10.1126/science.1092089
114. Rahdar, M., Inoue, T., Meyer, T., Zhang, J., Vazquez, F., and Devreotes, P. N. (2009). A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc. Natl. Acad. Sci. U.S.A. 106, 480-485. doi: 10.1073/pnas.0811212106
115. Raposo, G., and Stoorvogel, W. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383. doi: 10.1083/jcb.201211138
116. Redfern, R. E., Daou, M. C., Li, L., Munson, M., Gericke, A., and Ross, A. H. (2010). A mutant form of PTEN linked to autism. Protein Sci. 19, 1948-1956. doi: 10.1002/pro.483
117. Redfern, R. E., Redfern, D., Furgason, M. L., Munson, M., Ross, A. H., and Gericke, A. (2008). PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes. Biochemistry (Mosc.) 47, 2162-2171. doi: 10.1021/bi702114w
118. Ries, V., Henchcliffe, C., Kareva, T., Rzhetskaya, M., Bland, R., During, M. J., et al. (2006). Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 18757-18762. doi: 10.1073/pnas.0606401103
119. Rodríguez-Escudero, I., Oliver, M. D., Andrés-Pons, A., Molina, M., Cid, V. J., and Pulido, R. (2011). A comprehensive functional analysis of PTEN mutations: implications in tumor-and autism-related syndromes. Hum. Mol. Genet. 20, 4132-4142. doi: 10.1093/hmg/ddr337
120. Ross, A. H., and Gericke, A. (2009). Phosphorylation keeps PTEN phosphatase closed for business. Proc. Natl. Acad. Sci. U.S.A. 106, 1297-1298. doi: 10.1073/pnas.0812473106
121. Sanchez, T., Thangada, S., Wu, M. T., Kontos, C. D., Wu, D., Wu, H., et al. (2005). PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 102, 4312-4317. doi: 10.1073/pnas.0409784102
122. Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., et al. (2007). Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157-170. doi: 10.1016/j.cell.2006.11.042
123. Shenoy, S., Shekhar, P., Heinrich, F., Daou, M. C., Gericke, A., Ross, A. H., et al. (2012). Membrane association of the PTEN tumor suppressor: molecular details of the protein-membrane complex from SPR binding studies and neutron reflection. PLoS ONE 7:e32591. doi: 10.1371/journal.pone.0032591
124. Shewan, A., Eastburn, D. J., and Mostov, K. (2011). Phosphoinositides in cell architecture. Cold Spring Harb. Perspect. Biol. 3:a004796. doi: 10.1101/cshperspect.a004796
125. Shi, Y., Paluch, B. E., Wang, X., and Jiang, X. (2012). PTEN at a glance. J. Cell Sci. 125, 4687-4692. doi: 10.1242/jcs.093765
126. Song, M. S., Carracedo, A., Salmena, L., Song, S. J., Egia, A., Malumbres, M., et al. (2011). Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144, 187-199. doi: 10.1016/j.cell.2010.12.020
127. Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., et al. (2008). The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813-817. doi: 10.1038/nature07290
128. Song, M. S., Salmena, L., and Pandolfi, P. P. (2012). The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296. doi: 10.1038/nrm3330
129. Sonoda, Y., Mukai, H., Matsuo, K., Takahashi, M., Ono, Y., Maeda, K., et al. (2010). Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles. Neurosci. Lett. 471, 20-24. doi: 10.1016/j.neulet.2009.12.078
130. Sperow, M., Berry, R. B., Bayazitov, I. T., Zhu, G., Baker, S. J., and Zakharenko, S. S. (2012). Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration. J. Physiol. 590, 777-792. doi: 10.1113/jphysiol.2011.220236
131. Spillane, M., Ketschek, A., Jones, S. L., Korobova, F., Marsick, B., Lanier, L., et al. (2011). The actin nucleating Arp2/3 complex contributes to the formation of axonal filopodia and branches through the regulation of actin patch precursors to filopodia. Dev. Neurobiol. 71, 747-758. doi: 10.1002/dneu.20907
132. Sumitomo, M., Iwase, A., Zheng, R., Navarro, D., Kaminetzky, D., Shen, R., et al. (2004). Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell 5, 67-78. doi: 10.1016/S1535-6108(03)00331-3
133. Sun, F., Park, K. K., Belin, S., Wang, D., Lu, T., Chen, G., et al. (2011). Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480, 372-375. doi: 10.1038/nature10594
134. Takeuchi, K., Gertner, M. J., Zhou, J., Parada, L. F., Bennett, M. V. L., and Zukin, R. S. (2013). Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism. Proc. Natl. Acad. Sci. U.S.A. 110, 4738-4743. doi: 10.1073/pnas.1222803110
135. Tamura, M., Gu, J., Danen, E. H., Takino, T., Miyamoto, S., and Yamada, K. M. (1999). PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 274, 20693-20703. doi: 10.1074/jbc.274.29.20693
136. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K. M. (1998). Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617. doi: 10.1126/science.280.5369.1614
137. Terrien, E., Chaffotte, A., Lafage, M., Khan, Z., Préhaud, C., Cordier, F., et al. (2012). Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN. Sci. Signal. 5:ra58. doi: 10.1126/scisignal.2002941
138. Tibarewal, P., Zilidis, G., Spinelli, L., Schurch, N., Maccario, H., Gray, A., et al. (2012). PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity. Sci. Signal. 5, ra18. doi: 10.1126/scisignal.2002138
139. Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., et al. (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141-156. doi: 10.1016/j.cell.2006.11.040
140. Ueda, Y., and Hayashi, Y. (2013). PIP3 regulates spinule formation in dendritic spines during structural long-term potentiation. J. Neurosci. 33, 11040-11047. doi: 10.1523/JNEUROSCI.3122-12.2013
141. Van Diepen, M. T., and Eickholt, B. J. (2008). Function of PTEN during the formation and maintenance of neuronal circuits in the brain. Dev. Neurosci. 30, 59-64. doi: 10.1159/000109852
142. Van Diepen, M. T., Parsons, M., Downes, C. P., Leslie, N. R., Hindges, R., and Eickholt, B. J. (2009). MyosinV controls PTEN function and neuronal cell size. Nat. Cell Biol. 11, 1191-1196. doi: 10.1038/ncb1961
143. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., and Bilanges, B. (2010). The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell Biol. 11, 329-341. doi: 10.1038/nrm2882
144. Vanhaesebroeck, B., Stephens, L., and Hawkins, P. (2012). PI3K signalling: the path to discovery and understanding. Nat. Rev. Mol. Cell Biol. 13, 195-203. doi: 10.1038/nrm3290
145. Varga, E. A., Pastore, M., Prior, T., Herman, G. E., and McBride, K. L. (2009). The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet. Med. 11, 111-117. doi: 10.1097/GIM.0b013e31818fd762
146. Vazquez, F., and Devreotes, P. (2006). Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 5, 1523-1527. doi: 10.4161/cc.5.14.3005
147. Vazquez, F., Grossman, S. R., Takahashi, Y., Rokas, M. V., Nakamura, N., and Sellers, W. R. (2001). Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276, 48627-48630. doi: 10.1074/jbc.C100556200
148. Vazquez, F., Matsuoka, S., Sellers, W. R., Yanagida, T., Ueda, M., and Devreotes, P. N. (2006). Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 103, 3633-3638. doi: 10.1073/pnas.0510570103
149. Von Stein, W., Ramrath, A., Grimm, A., Muller-Borg, M., and Wodarz, A. (2005). Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling. Development 132, 1675-1686. doi: 10.1242/dev.01720
150. Waite, K., and Eickholt, B. J. (2010). The neurodevelopmental implications of PI3K signaling. Curr. Top. Microbiol. Immunol. 346, 245-265. doi: 10.1007/82_2010_82
151. Walker, C. L., Walker, M. J., Liu, N.-K., Risberg, E. C., Gao, X., Chen, J., et al. (2012). Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury. PloS ONE 7:e30012. doi: 10.1371/journal.pone.0030012
152. Walker, S. M., Leslie, N. R., Perera, N. M., Batty, I. H., and Downes, C. P. (2004). The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem. J. 379, 301-307. doi: 10.1042/BJ20031839
153. Wei, W., Wang, X., and Kusiak, J. W. (2002). Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277, 17649-17656. doi: 10.1074/jbc.M111704200
154. Welch, H. C. E., Coadwell, W. J., Ellson, C. D., Ferguson, G. J., Andrews, S. R., Erdjument-Bromage, H., et al. (2002). P-Rex1, a PtdIns(3,4,5)P3-and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 108, 809-821. doi: 10.1016/S0092-8674(02)00663-3
155. Won, H., Mah, W., and Kim, E. (2013). Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front. Mol. Neurosci. 6:19. doi: 10.3389/fnmol.2013.00019
156. Worth, D. C., Daly, C. N., Geraldo, S., Oozeer, F., and Gordon-Weeks, P. R. (2013). Drebrin contains a cryptic F-actin-bundling activity regulated by Cdk5 phosphorylation. J. Cell Biol. 202, 793-806. doi: 10.1083/jcb.201303005
157. Wu, H., Feng, W., Chen, J., Chan, L. N., Huang, S., and Zhang, M. (2007). PDZ domains of Par-3 as potential phosphoinositide signaling integrators. Mol. Cell 28, 886-898. doi: 10.1016/j.molcel.2007.10.028
158. Wu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M. B., Yuan, X. J., et al. (2000). Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc. Natl. Acad. Sci. U.S.A. 97, 4233-4238. doi: 10.1073/pnas.97.8.4233
159. Yin, H. L., and Janmey, P. A. (2003). Phosphoinositide regulation of the actin cytoskeleton. Annu. Rev. Physiol. 65, 761-789. doi: 10.1146/annurev.physiol.65.092101.142517
160. Yoshinaga, S., Ohkubo, T., Sasaki, S., Nuriya, M., Ogawa, Y., Yasui, M., et al. (2012). A phosphatidylinositol lipids system, lamellipodin, and Ena/VASP regulate dynamic morphology of multipolar migrating cells in the developing cerebral cortex. J. Neurosci. 32, 11643-11656. doi: 10.1523/JNEUROSCI.0738-12.2012
161. Zhang, S., Taghibiglou, C., Girling, K., Dong, Z., Lin, S.-Z., Lee, W., et al. (2013). Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries. J. Neurosci. 33, 7997-8008. doi: 10.1523/JNEUROSCI.5661-12.2013
162. Zhang, X., Li, F., Bulloj, A., Zhang, Y.-W., Tong, G., Zhang, Z., et al. (2006). Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules. FASEB J. 20, 1272-1274. doi: 10.1096/fj.06-5721fje
163. Zhang, X. C., Piccini, A., Myers, M. P., Van Aelst, L., and Tonks, N. K. (2012a). Functional analysis of the protein phosphatase activity of PTEN. Biochem. J. 444, 457-464. doi: 10.1042/BJ20120098
164. Zhang, Y., Granholm, A.-C., Huh, K., Shan, L., Diaz-Ruiz, O., Malik, N., et al. (2012b). PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice. Brain 135, 2736-2749. doi: 10.1093/brain/aws196
165. Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., et al. (2009). Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J. Neurosci. 29, 1773-1783. doi: 10.1523/JNEUROSCI.5685-08.2009
166. Zhou, J., and Parada, L. F. (2012). PTEN signaling in autism spectrum disorders. Curr. Opin. Neurobiol. 22, 873-879. doi: 10.1016/j.conb.2012.05.004
167. Zhu, Y., Hoell, P., Ahlemeyer, B., and Krieglstein, J. (2006). PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis 11, 197-207. doi: 10.1007/s10495-006-3714-5
168. Zhu, Y., Hoell, P., Ahlemeyer, B., Sure, U., Bertalanffy, H., and Krieglstein, J. (2007). Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease. Neurochem. Int. 50, 507-516. doi: 10.1016/j.neuint.2006.10.010
169. Zu, L., Zheng, X., Wang, B., Parajuli, N., Steenbergen, C., Becker, L. C., et al. (2011). Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 300, H2177-H2186. doi: 10.1152/ajpheart.01138.2010
170. Zukor, K., Belin, S., Wang, C., Keelan, N., Wang, X., and He, Z. (2013). Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. J. Neurosci. 33, 15350-15361. doi: 10.1523/JNEUROSCI.2510-13.2013